These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 10385698

  • 1. Phosphodiesterase 4B2 is the predominant phosphodiesterase species and undergoes differential regulation of gene expression in human monocytes and neutrophils.
    Wang P, Wu P, Ohleth KM, Egan RW, Billah MM.
    Mol Pharmacol; 1999 Jul; 56(1):170-4. PubMed ID: 10385698
    [Abstract] [Full Text] [Related]

  • 2. Phosphodiesterase 4B gene transcription is activated by lipopolysaccharide and inhibited by interleukin-10 in human monocytes.
    Ma D, Wu P, Egan RW, Billah MM, Wang P.
    Mol Pharmacol; 1999 Jan; 55(1):50-7. PubMed ID: 9882697
    [Abstract] [Full Text] [Related]

  • 3. Differential expression and function of phosphodiesterase 4 (PDE4) subtypes in human primary CD4+ T cells: predominant role of PDE4D.
    Peter D, Jin SL, Conti M, Hatzelmann A, Zitt C.
    J Immunol; 2007 Apr 15; 178(8):4820-31. PubMed ID: 17404263
    [Abstract] [Full Text] [Related]

  • 4. Induction of the cyclic nucleotide phosphodiesterase PDE4B is essential for LPS-activated TNF-alpha responses.
    Jin SL, Conti M.
    Proc Natl Acad Sci U S A; 2002 May 28; 99(11):7628-33. PubMed ID: 12032334
    [Abstract] [Full Text] [Related]

  • 5. Suppression of human inflammatory cell function by subtype-selective PDE4 inhibitors correlates with inhibition of PDE4A and PDE4B.
    Manning CD, Burman M, Christensen SB, Cieslinski LB, Essayan DM, Grous M, Torphy TJ, Barnette MS.
    Br J Pharmacol; 1999 Dec 28; 128(7):1393-8. PubMed ID: 10602317
    [Abstract] [Full Text] [Related]

  • 6. Prolonged beta adrenoceptor stimulation up-regulates cAMP phosphodiesterase activity in human monocytes by increasing mRNA and protein for phosphodiesterases 4A and 4B.
    Manning CD, McLaughlin MM, Livi GP, Cieslinski LB, Torphy TJ, Barnette MS.
    J Pharmacol Exp Ther; 1996 Feb 28; 276(2):810-8. PubMed ID: 8632354
    [Abstract] [Full Text] [Related]

  • 7. Regulation of distinct cyclic AMP-specific phosphodiesterase (phosphodiesterase type 4) isozymes in human monocytic cells.
    Verghese MW, McConnell RT, Lenhard JM, Hamacher L, Jin SL.
    Mol Pharmacol; 1995 Jun 28; 47(6):1164-71. PubMed ID: 7603456
    [Abstract] [Full Text] [Related]

  • 8. Differential expression of PDE4 cAMP phosphodiesterase isoforms in inflammatory cells of smokers with COPD, smokers without COPD, and nonsmokers.
    Barber R, Baillie GS, Bergmann R, Shepherd MC, Sepper R, Houslay MD, Heeke GV.
    Am J Physiol Lung Cell Mol Physiol; 2004 Aug 28; 287(2):L332-43. PubMed ID: 15047569
    [Abstract] [Full Text] [Related]

  • 9. Effect of pregnancy on PDE4 cAMP-specific phosphodiesterase messenger ribonucleic acid expression in human myometrium.
    Leroy MJ, Méhats C, Duc-Goiran P, Tanguy G, Robert B, Dallot E, Mignot TM, Grangé G, Ferré F.
    Cell Signal; 1999 Jan 28; 11(1):31-7. PubMed ID: 10206342
    [Abstract] [Full Text] [Related]

  • 10. Regulation of cAMP-specific phosphodiesterases type 4B and 4D (PDE4) splice variants by cAMP signaling in primary cortical neurons.
    D'Sa C, Tolbert LM, Conti M, Duman RS.
    J Neurochem; 2002 May 28; 81(4):745-57. PubMed ID: 12065634
    [Abstract] [Full Text] [Related]

  • 11. S-adenosylmethionine decreases lipopolysaccharide-induced phosphodiesterase 4B2 and attenuates tumor necrosis factor expression via cAMP/protein kinase A pathway.
    Gobejishvili L, Avila DV, Barker DF, Ghare S, Henderson D, Brock GN, Kirpich IA, Joshi-Barve S, Mokshagundam SP, McClain CJ, Barve S.
    J Pharmacol Exp Ther; 2011 May 28; 337(2):433-43. PubMed ID: 21266552
    [Abstract] [Full Text] [Related]

  • 12. Remodelling of the PDE4 cAMP phosphodiesterase isoform profile upon monocyte-macrophage differentiation of human U937 cells.
    Shepherd MC, Baillie GS, Stirling DI, Houslay MD.
    Br J Pharmacol; 2004 May 28; 142(2):339-51. PubMed ID: 15066910
    [Abstract] [Full Text] [Related]

  • 13. Interleukin-1beta induces phosphodiesterase 4B2 expression in human myometrial cells through a prostaglandin E2- and cyclic adenosine 3',5'-monophosphate-dependent pathway.
    Oger S, Méhats C, Dallot E, Ferré F, Leroy MJ.
    J Clin Endocrinol Metab; 2002 Dec 28; 87(12):5524-31. PubMed ID: 12466348
    [Abstract] [Full Text] [Related]

  • 14. Selective up-regulation of phosphodiesterase-4 cyclic adenosine 3',5'-monophosphate (cAMP)-specific phosphodiesterase variants by elevated cAMP content in human myometrial cells in culture.
    Méhats C, Tanguy G, Dallot E, Robert B, Rebourcet R, Ferré F, Leroy MJ.
    Endocrinology; 1999 Jul 28; 140(7):3228-37. PubMed ID: 10385419
    [Abstract] [Full Text] [Related]

  • 15. Noradrenergic lesions differentially alter the expression of two subtypes of low Km cAMP-sensitive phosphodiesterase type 4 (PDE4A and PDE4B) in rat brain.
    Farooqui SM, Zhang K, Makhay M, Jackson K, Farooqui SQ, Cherry JA, O'Donnell JM.
    Brain Res; 2000 Jun 09; 867(1-2):52-61. PubMed ID: 10837797
    [Abstract] [Full Text] [Related]

  • 16. Splice variants of the cyclic nucleotide phosphodiesterase PDE4D are differentially expressed and regulated in rat tissue.
    Richter W, Jin SL, Conti M.
    Biochem J; 2005 Jun 15; 388(Pt 3):803-11. PubMed ID: 15717866
    [Abstract] [Full Text] [Related]

  • 17. Phosphodiesterase (PDE) 7 in inflammatory cells from patients with asthma and COPD.
    Jones NA, Leport M, Holand T, Vos T, Morgan M, Fink M, Pruniaux MP, Berthelier C, O'Connor BJ, Bertrand C, Page CP.
    Pulm Pharmacol Ther; 2007 Jun 15; 20(1):60-8. PubMed ID: 16427796
    [Abstract] [Full Text] [Related]

  • 18. Selective induction of cAMP phosphodiesterase PDE4B2 expression in experimental autoimmune encephalomyelitis.
    Reyes-Irisarri E, Sánchez AJ, García-Merino JA, Mengod G.
    J Neuropathol Exp Neurol; 2007 Oct 15; 66(10):923-31. PubMed ID: 17917586
    [Abstract] [Full Text] [Related]

  • 19. Histamine up-regulates phosphodiesterase 4 activity and reduces prostaglandin E2-inhibitory effects in human neutrophils.
    Dasí FJ, Ortiz JL, Cortijo J, Morcillo EJ.
    Inflamm Res; 2000 Nov 15; 49(11):600-9. PubMed ID: 11131300
    [Abstract] [Full Text] [Related]

  • 20. Altered expression of PDE1 and PDE4 cyclic nucleotide phosphodiesterase isoforms in 7-oxo-prostacyclin-preconditioned rat heart.
    Kostic MM, Erdogan S, Rena G, Borchert G, Hoch B, Bartel S, Scotland G, Huston E, Houslay MD, Krause EG.
    J Mol Cell Cardiol; 1997 Nov 15; 29(11):3135-46. PubMed ID: 9405187
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.